These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38849096)

  • 1. Protein nanoparticles as drug delivery systems for cancer theranostics.
    Hua Y; Qin Z; Gao L; Zhou M; Xue Y; Li Y; Xie J
    J Control Release; 2024 Jul; 371():429-444. PubMed ID: 38849096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.
    Elzoghby AO; Hemasa AL; Freag MS
    J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics.
    Bose RJ; Paulmurugan R; Moon J; Lee SH; Park H
    Drug Discov Today; 2018 Apr; 23(4):891-899. PubMed ID: 29426004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein nanoparticles as drug delivery carriers for cancer therapy.
    Lohcharoenkal W; Wang L; Chen YC; Rojanasakul Y
    Biomed Res Int; 2014; 2014():180549. PubMed ID: 24772414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
    Huang D; He B; Mi P
    Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
    Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
    Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
    Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles Based on Plasma Proteins for Drug Delivery Applications.
    Tezcaner A; Baran ET; Keskin D
    Curr Pharm Des; 2016; 22(22):3445-54. PubMed ID: 26861647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Persistent Luminescence Nanoparticles for Biological Applications: From Biosensing/Bioimaging to Theranostics.
    Sun SK; Wang HF; Yan XP
    Acc Chem Res; 2018 May; 51(5):1131-1143. PubMed ID: 29664602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinspired approaches for cancer nanotheranostics.
    Evangelopoulos M; Tasciotti E
    Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
    [No Abstract]   [Full Text] [Related]  

  • 13. Theranostic application of nanoemulsions in chemotherapy.
    Gorain B; Choudhury H; Nair AB; Dubey SK; Kesharwani P
    Drug Discov Today; 2020 Jul; 25(7):1174-1188. PubMed ID: 32344042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
    Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
    Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-targeted nanomedicines for cancer theranostics.
    Arranja AG; Pathak V; Lammers T; Shi Y
    Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
    Hou L; Shan X; Hao L; Feng Q; Zhang Z
    Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
    Mohammadi M; Ramezani M; Abnous K; Alibolandi M
    Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan Nanoparticles-Insight into Properties, Functionalization and Applications in Drug Delivery and Theranostics.
    Jhaveri J; Raichura Z; Khan T; Momin M; Omri A
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33430478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.